Zhenliang Wen

Ruijin Hospital — China

Medicine · Health Sciences

13h-index768citations34works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(10), Sepsis Diagnosis and Treatment(10), SARS-CoV-2 and COVID-19 Research(5), Immune Response and Inflammation(3), Immune Cell Function and Interaction(3)

Publications34 total

Study on the correlation between carbapenem-resistant Klebsiella pneumoniae infection strains and intestinal colonization strains in intensive care unit of a tertiary hospital in China
Journal of Global Antimicrobial Resistance·2025· 1 citedOpen Access
Network pharmacology, molecular docking, and experimental verification reveal the mechanism of Yi-Shen-Hua-Shi granules treating acute kidney injury
Journal of Ethnopharmacology·2025· 3 cited
Trends and predictions of maternal sepsis and other maternal infections among women of childbearing age: a systematic analysis for the global burden of disease study 2019
Frontiers in Public Health·2024· 6 citedOpen Access
The causal role of immune cells in susceptibility and severity of COVID-19: A bidirectional Mendelian randomization study
Journal of Intensive Medicine·2024Open Access
Network Pharmacology, Molecular Docking, And Experimental Verification Reveal The Mechanism of Yi-Shen-Hua-Shi Granules  Treating Acute Kidney Injury
SSRN Electronic Journal·2024Open Access
Herpesvirus reactivation in respiratory tract is associated with increased mortality of severe pneumonia patients and their respiratory microbiome dysbiosis
Frontiers in Cellular and Infection Microbiology·2023· 11 citedOpen Access
Association of autoimmune diseases with the occurrence and 28-day mortality of sepsis: an observational and Mendelian randomization study
Critical Care·2023· 28 citedOpen Access
Thymopentin plays a key role in restoring the function of macrophages to alleviate the sepsis process
International Immunopharmacology·2023· 2 cited
Association of autoimmune diseases with the occurrence and 28-day mortality of sepsis: an observational and Mendelian randomization study
Research Square (Research Square)·2023· 2 citedOpen Access
Human blood metabolites and risk of severe <scp>COVID</scp>‐19: A Mendelian randomization study
European Journal of Clinical Investigation·2023· 4 citedOpen Access
ATF4 knockdown in macrophage impairs glycolysis and mediates immune tolerance by targeting HK2 and HIF-1α ubiquitination in sepsis
Clinical Immunology·2023· 50 citedOpen Access
Association of gut microbiota with COVID‐19 susceptibility and severity: A two‐sample Mendelian randomization study
Journal of Medical Virology·2023· 15 cited
Association between Mean Arterial Pressure during the First 24 Hours and Clinical Outcome in Critically Ill Stroke Patients: An Analysis of the MIMIC-III Database
Journal of Clinical Medicine·2023· 4 citedOpen Access
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
The Lancet Regional Health - Western Pacific·2023· 109 citedOpen Access
Activating transcription factor 4 protects mice against sepsis-induced intestinal injury by regulating gut-resident macrophages differentiation
Chinese Medical Journal·2022· 4 citedOpen Access
Lipopolysaccharide induced intestinal epithelial injury: a novel organoids-based model for sepsis in vitro
Chinese Medical Journal·2022· 26 citedOpen Access
Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case–control study
Annals of Intensive Care·2022· 40 citedOpen Access
Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study
Frontiers in Immunology·2021· 25 citedOpen Access
Identification and validation of prognostic factors in patients with COVID-19: A retrospective study based on artificial intelligence algorithms
Journal of Intensive Medicine·2021· 12 citedOpen Access
Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study
Clinical Microbiology and Infection·2021· 19 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Sisi Huang(20), Yizhu Chen(18), Lidi Zhang(17), Dechang Chen(16), Jiao Liu(14), Dechang Chen(14), Hangxiang Du(13), Sheng Zhang(12), Xiaojun Pan(10), Yongan Liu(8), Limin Chen(8), Xuan Dong(7), Tao Wang(7), Jiao Liu(6), Xuan Shen(6), Weifeng Shang(6), Qianghong Xu(5), Djillali Annane(5), Jieming Qu(5), Huibin Feng(4)